Jin Wang

Title: Jin Wang - Innovator in Sustained Release Formulations

Introduction

Jin Wang is a notable inventor based in Cedar Grove, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of sustained release medications. His innovative approach has the potential to enhance patient care and medication efficacy.

Latest Patents

Jin Wang holds a patent for a sustained release formulation containing acetaminophen and tramadol. This formulation is designed as a unit dose that includes 100 mg-1000 mg of acetaminophen and 15 mg-150 mg of tramadol hydrochloride. The formulation consists of an immediate release portion that comprises 25%-75% of the total effective amount of the drug and a sustained release portion that includes gelling polymers and an optional enteric coating. The dissolution profile of this formulation demonstrates that it dissolves 25%-60% of the total drug in the first hour, 50%-90% in the first four hours, and not less than 80% in the first 12 hours using the USP dissolution method II at 50 rpm.

Career Highlights

Throughout his career, Jin Wang has focused on developing innovative drug delivery systems. His work has been instrumental in advancing the field of sustained release formulations, which are crucial for improving therapeutic outcomes in patients.

Collaborations

Jin Wang collaborates with Shuyi Zhang, who is also involved in the research and development of pharmaceutical formulations. Their partnership has contributed to the advancement of innovative solutions in the industry.

Conclusion

Jin Wang's contributions to sustained release formulations highlight his role as an important inventor in the pharmaceutical field. His innovative work continues to pave the way for improved medication delivery systems.